NOW – a Crowdfunding campaign to connect scientific research to the world of patients by supporting four cancer patients’ associations. Scientific research is essential for the well-being of society, but quite often it takes many years to collect the results from our research with no immediate effect on the patients. The timing of research and […]
Cancer cells are surrounded by a diverse range of “normal cells” known as the stroma. The stroma includes immune cells, endothelial cells, fibroblasts and the extracellular matrix scaffold they produce. Together cancer cells and stroma form the tumour microenvironment. Crosstalk between the tumour and stroma is critical to help a tumour form and grow, but […]
An analysis by Claudia Langenberg (MRC Epidemiology Unit) and collaborators from UCL, University College London Hospitals NHS Foundation Trust, and Health Data Research UK, indicates that at least 20% of the UK population has a high-risk underlying condition for COVID-19 infection listed by Public Health England. The authors have created a publicly accessible COVID-19 risk calculator showing how […]
One of Cambridge’s newest institutes, established to study the relationship between infectious disease and our immune systems, is leading the University of Cambridge’s response to the COVID-19 pandemic, with over 150 scientists and clinicians, the UK’s largest academic Containment Level 3 Facility, and a range of collaborators from across the UK and beyond.
UK National Cancer Imaging Translational Accelerator (NCITA) establishes infrastructure for validation and adoption of cancer imaging biomarkers as decision-making tools in clinical trials and NHS practice. Researchers and medical experts from nine world-leading medical imaging centres across the UK come together to form an integrated infrastructure for standardising and validating cancer imaging biomarkers for clinical […]